米国連結子会社の米国会計基準変更に伴う調整、その他、営業活動によるキャッシュ・フロー（IFRS）他2件
- 【期間】
| 年度 | 米国連結子会社の米国会計基準変更に伴う調整 | その他 | 営業活動によるキャッシュ・フロー（IFRS） | のれん - ＥＭＥＡ医薬品事業 | 投資有価証券評価損 |
|---|
| 2008/03 | 281百万 | | 164億 | | - | | - | | 14.2億 | |
| 2009/03 | - | | - | | - | | - | | 84億 | +491.4% |
| 2009/12 | - | | - | | - | | - | | - | |
| 2010/03 | - | | - | | - | | - | | - | |
| 2010/06 | - | | - | | - | | - | | 3.21億 | -96.2% |
| 2010/09 | - | | - | | - | | - | | 3.5億 | +9% |
| 2010/12 | - | | - | | - | | - | | 2.77億 | -20.9% |
| 2011/03 | - | | - | | - | | - | | 6.37億 | +130% |
| 2011/06 | - | | - | | - | | - | | - | |
| 2011/09 | - | | - | | - | | - | | - | |
| 2011/12 | - | | - | | - | | - | | 2.06億 | -67.7% |
| 2012/03 | - | | - | | - | | - | | - | |
| 2012/06 | - | | - | | - | | - | | 2.82億 | +36.9% |
| 2012/09 | - | | - | | - | | - | | 2.95億 | +4.6% |
| 2012/12 | - | | - | | - | | - | | 2.5億 | -15.3% |
| 2013/03 | - | | - | | - | | 402百万 | | - | |
| 2013/06 | - | | - | | - | | - | | - | |
| 2013/09 | - | | - | | - | | - | | - | |
| 2013/12 | - | | - | | - | | - | | - | |
| 2014/03 | - | | - | | - | | 322百万 | -19.9% | 2.81億 | +12.4% |
| 2016/03 | - | | - | | - | | - | | 1.41億 | -49.8% |
| 2018/03 | - | | - | | 1496億 | | - | | - | |
| 2018/06 | - | | - | | 123億 | -91.8% | - | | - | |
| 2018/09 | - | | - | | 499億 | +304.4% | - | | - | |
| 2018/12 | - | | - | | 605億 | +21.1% | - | | - | |
| 2019/03 | - | | - | | 1037億 | +71.5% | - | | - | |
| 2019/06 | - | | - | | -40.7億 | 赤転 | - | | - | |
| 2019/09 | - | | - | | 84.4億 | 黒転 | - | | - | |
| 2019/12 | - | | - | | 292億 | +246.1% | - | | - | |
| 2020/03 | - | | - | | 1028億 | +251.8% | - | | - | |
| 2020/06 | - | | - | | 100億 | -90.2% | - | | - | |
| 2020/09 | - | | - | | 187億 | +85.6% | - | | - | |
| 2020/12 | - | | - | | 221億 | +18.5% | - | | - | |
| 2021/03 | - | | - | | 739億 | +234.1% | - | | - | |
| 2021/06 | - | | - | | -143億 | 赤転 | - | | - | |
| 2021/09 | - | | - | | 684億 | 黒転 | - | | - | |
| 2021/12 | - | | - | | 732億 | +7% | - | | - | |
| 2022/03 | - | | - | | 1176億 | +60.7% | - | | 0.4億 | -71.6% |
| 2022/06 | - | | - | | 39.5億 | -96.6% | - | | - | |
| 2022/09 | - | | - | | -188億 | 赤転 | - | | - | |
| 2022/12 | - | | - | | -258億 | 赤拡 | - | | - | |
| 2023/03 | - | | - | | -17.7億 | 赤縮 | - | | 0.39億 | -2.5% |
| 2023/06 | - | | - | | 126億 | 黒転 | - | | - | |
| 2023/09 | - | | - | | 293億 | +131.5% | - | | - | |
| 2023/12 | - | | - | | 379億 | +29.6% | - | | - | |
| 2024/03 | - | | - | | 560億 | +47.6% | - | | - | |
| 2024/06 | - | | - | | -85.8億 | 赤転 | - | | - | |
| 2024/09 | - | | - | | 8.81億 | 黒転 | - | | - | |
